Natco Pharma Limited
NATCOPHARM

Natco Pharma Limited

Pharmaceuticals
Share price
₹824
Market cap
₹16,158 Cr
1Y return
▲ 2%

A vertically integrated pharmaceutical company engaged in developing, manufacturing, and marketing complex products for niche therapeutic areas. Natco Pharma operates across three core business segments: finished dosage formulations, active pharmaceutical ingredients, and contract manufacturing services. The company maintains a strong research and development focus to drive innovation and develop specialized therapeutic solutions across oncology, cardiovascular, gastroenterology, and other critical therapeutic domains.

Investors holding Natco Pharma Limited

B
Belgrave
Foreign Investor
2.31%
LIC
LIC
Institution
2.24%
1.01%

Recent moves 3

Durga Devi Nannapaneni
24 Aug 2026. Sign in to see this move
LICNew position
LIC initiated a new position in Natco Pharma, acquiring 40,09,317 shares, representing a 2.24% stake. The investment is valued at ₹385.54 Cr based on Natco Pharma's share price of ₹961.60.
9 Jul 2026
Read more
SANJAY NANNAPANENI and SATYA VANI NANNAPANENIDecreased
Sanjay Nannapaneni and Satya Vani Nannapaneni sold 1.15 lakh shares of Natco Pharma for ₹11.63 Cr at ₹1017.31 apiece, reducing the promoter group's stake from 0.13% to 0.09%.
9 Mar 2026
Read more

Track the whales in Natco Pharma Limited

Get alerted the moment a top investor buys or sells.

Get started